Evidence map›Paper›PMID 38468404›Full record

Trial reportPsychiatry and clinical neurosciences2024

Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study).

Tatsuo Akechi, Toshiaki A Furukawa, Hisashi Noma, Hiroji Iwata, Tatsuya Toyama, Kenji Higaki, Hiromichi Matsuoka, Sadamoto Zenda, Tsuguo Iwatani, Kazuhisa Akahane and 21 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Psychiatry and clinical neurosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Tatsuo AkechiDepartment of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.ORCID https://orcid.org/0000-0003-1100-7518
Toshiaki A FurukawaDepartment of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
Hisashi NomaDepartment of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan.
Hiroji IwataDepartment of Breast Oncology, Aichi Cancer Center, Nagoya, Japan.
Tatsuya ToyamaDepartment of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Kenji HigakiHigaki Breast Clinic, Hiroshima, Japan.
Hiromichi MatsuokaDepartment of Psycho-Oncology, National Cancer Center Hospital, Tokyo, Japan.
Sadamoto ZendaDivision of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
Tsuguo IwataniDepartment of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Kazuhisa AkahaneAkahane Breast Clinic, Nagoya, Japan.
Akira InoueDepartment of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan.
Yasuaki SagaraDepartment of Breast and Thyroid Surgical Oncology, Hakuaikai Medical Corporation, Sagara Hospital, Kagoshima, Japan.
Megumi UchidaDepartment of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Fuminobu ImaiDepartment of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Kanae MominoDepartment of Nursing Administration and Management, Nagoya City University Graduate School of Nursing, Nagoya, Japan.
Gen ImaizumiDepartment of Psychiatric and Mental Health Nursing, Nagoya City University Graduate School of Nursing, Nagoya, Japan.
Takuhiro YamaguchiDivision of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tomoe MashikoDivision of Survivorship, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
Tempei MiyajiDivision of Survivorship, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
Masaru HorikoshiNational Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Tokyo, Japan.
Naomi SakuraiCancer Solutions, Tokyo, Japan.
Tatsuya OnishiDepartment of Breast Surgery, National Cancer Center Hospital East, Chiba, Japan.
Yukihide KanemitsuDepartment of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
Takeshi MurataDepartment of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan.
Yumi Wanifuchi-EndoDepartment of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Hiroaki KurodaDepartment of Thoracic Surgery, Aichi Cancer Center, Nagoya, Japan.
Ryutaro NishikawaDepartment of Obstetrics and Gynecology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Minoru MiyashitaDepartment of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Masakazu AbeDepartment of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Shizuoka, Japan.
Yosuke UchitomiDivision of Survivorship, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
J‐SUPPORT 2001 Study group

Funding

Japan Agency for Medical Research and Development 20ck0106600h0001Japanese Ministry of Education, Culture, Science and Technology 19H03586
6 · The paper itself

Abstract

aimPatients with cancer experience various forms of psychological distress, including depressive symptoms, which can impact quality of life, elevate morbidity risk, and increase medical costs. Psychotherapy and pharmacotherapy are effective for reducing depressive symptoms among patients with cancer, but most patients prefer psychotherapy. This study aimed to develop an efficient and effective smartphone psychotherapy component to address depressive symptom.

methodsThis was a decentralized, parallel-group, multicenter, open, individually randomized, fully factorial trial. Patients aged ≥20 years with cancer were randomized by the presence/absence of three cognitive-behavioral therapy (CBT) skills (behavioral activation [BA], assertiveness training [AT], and problem-solving [PS]) on a smartphone app. All participants received psychoeducation (PE). The primary outcome was change in the patient health questionnaire-9 (PHQ-9) total score between baseline and week 8. Secondary outcomes included anxiety.

resultsIn total, 359 participants were randomized. Primary outcome data at week 8 were obtained for 355 participants (99%). The week 8 PHQ-9 total score was significantly reduced from baseline for all participants by -1.41 points (95% confidence interval [CI] -1.89, -0.92), but between-group differences in change scores were not significant (BA: -0.04, 95% CI -0.75, 0.67; AT: -0.16, 95% CI -0.87, 0.55; PS: -0.19, 95% CI -0.90, 0.52).

conclusionAs the presence of any of the three intervention components did not contribute to a significant additive reduction of depressive symptoms, we cannot make evidence-based recommendations regarding the use of specific smartphone psychotherapy.

Indexed as

Cognitive Behavioral TherapyDepressionNeoplasmsSmartphoneAdultAgedFemaleHumansMaleMiddle AgedMobile ApplicationsOutcome Assessment, Health CarePsychotherapydecentralized clinical trialdepressive symptomsmultiphase optimization strategyneoplasmsmartphone‐based CBT

Identifiers

PMID38468404
PMCPMC11488626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.